View full metadata

THIS DOI METADATA WAS LAST UPDATED: 2024-01-10 22:51

DOI data

10.3280/RIP2012-002016

Serial Article

Cite as

Journal Data
Journal Issue Data
Serial Article Data
Reference list of 10.3280/RIP2012-002016

Unstructured Citation

Bateman, R.J., Xiong, C., Benzinger, T.L., Fagan, A.M., Goate, A., Fox, N.C., Marcus, D.S., Cairns, N.J., Xie, X., Blazey, T.M., Holtzman, D.M., Santacruz, A., Buckles, V., Oliver, A., Moulder, K., Aisen, P.S., Ghetti, B., Klunk, W.E., McDade, E., Martins, R.N., Masters, C.L., Mayeux, R., Ringman, J.M., Rossor, M.N., Schofield, P.R., Sperling, R.A., Salloway, S., Morris, J.C., & Dominantly Inherited Alzheimer Network (2012). Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. The New England Journal of Medicine, 367, 795-804


Unstructured Citation

Bennett, D.A., Schneider, J.A., Bienias, J.L., Evans, D.A., & Wilson R.S. (2005). Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology, 64, 834-841.

https://doi.org/10.1212/01.WNL.0000152982.47274.9E


Unstructured Citation

Birks, J. (2006). Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database Syst Rev, CD005593


Unstructured Citation

Bowen, D.M., Smith, C.B., White, P., & Davison, A.N. (1976). Neurotransmitterrelated enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain, 99, 459-496

https://doi.org/10.1093/brain/99.3.459


Unstructured Citation

Braak, H., & Braak, E. (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica, 82, 239-259

https://doi.org/10.1007/BF00308809


Unstructured Citation

Braak, H., & Del Tredici, K. (2011). Alzheimer’s pathogenesis, is there neuron- to-neuron propagation? Acta Neuropathologica, 121, 589-595.

https://doi.org/10.1007/s00401-011-0825-z


Unstructured Citation

Chui, H.C., Zarow, C., Mack, W.J., Ellis, W.G., Zheng, L., & Jagust, W.J. (2006). Cognitive impact of subcortical vascular and Alzheimer’s disease pathology. Annals of Neurology, 60, 677-687

https://doi.org/10.1002/ana.21009


Unstructured Citation

Coleman, P.D., & Yao, P.J. (2003). Synaptic slaughter in Alzheimer’s disease. Neurobiology of Aging, 24, 1023-1027

https://doi.org/10.1016/j.neurobiolaging.2003.09.001


Unstructured Citation

DeKosky, S.T, Scheff, S.W., & Styren, S.D. (1996). Structural correlates of cognition in dementia, quantification and assessment of synapse change. Neurodegeneration, 5, 417-421

https://doi.org/10.1006/neur.1996.0056


Unstructured Citation

Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.M., Perez-tur, J., Hutton, M., Buee, L., Harigaya, Y., Yager, D., Morgan, D., Gordon, M.N., Holcomb, L., Refolo, L., Zenk, B., Hardy, J., & Younkin, S. (1996). Increased amyloid- beta42(43) in brains of mice expressing mutant presenilin 1. Nature, 383, 710-713.

https://doi.org/10.1038/383710a0


Unstructured Citation

Farina, E., Baglio, F., Caffarra, P., Magnani, G., Scarpini, E., Appollonio, I., Bascelli, C., Cheldi, A., Nemni, R., Franceschi, M., Italian Group for Lewy Body Dementia and Dementias Associated to Parkinsonism, Messa, G., Mantovani, F., Bellotti, M., Olivotto, F., Alberoni, M., Isella, V., Regazzoni, R., Schiatti, E,. Vismara, C., Falautano, M., Barbieri, A., Restelli, I., Fetoni, V., Donato, M., Zuffi, M., & Castiglioni S. (2009). Frequency and clinical features of Lewy body dementia in Italian memory clinics. Acta Biomedica, 80, 57-64.


Unstructured Citation

Fotuhi, M., Hachinski, V., & Whitehouse, P.J. (2009). Changing perspectives regarding late-life dementia. Nature Reviews Neurology, 5, 649-658.

https://doi.org/10.1038/nrneurol.2009.175


Unstructured Citation

Giannakopoulos, P., Herrmann, F.R., Bussière, T., Bouras C., Kövari E., Perl D. P., Morrison J.H., Gold G., & Hof, P.R. (2003). Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease. Neurology, 60, 1495-1500.

https://doi.org/10.1212/01.WNL.0000063311.58879.01


Unstructured Citation

Glenner, G.G., & Wong, C.W. (1984). Alzheimer’s disease and Down’s syndrome, sharing of a unique cerebrovascular amyloid fibril protein. Biochemical and Biophysical Research Communications, 122, 1131-1135

https://doi.org/10.1016/0006-291X(84)91209-9


Unstructured Citation

Gong, Y., Chang, L., Viola, K.L., Lambert, M.P., Frinch, C.E., Krafft, G.A., & Klein, W.L. (2003). Alzheimer’s disease-affected brain, presence of oligomeric A ligands (ADDLs) suggests a molecular basis for reversibile memory loss. Proceedings of the National Academy of Sciences of the United States of America, 100, 10417-10422.


Unstructured Citation

Grundke-Iqbal, I., Iqbal, K., Tung, Y.C., Quinlan, M., Wisniewski, H.M., & Binder, L.I. (1986). Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proceedings of the National Academy of Sciences of the United States of America, 83, 4913–4917

https://doi.org/10.1073/pnas.83.13.4913


Unstructured Citation

Hardy, J., & Selkoe, D.J. (2002). The amyloid hypothesis of Alzheimer’s disease, progress and problems on the road to therapeutics. Science, 297, 353-356

https://doi.org/10.1126/science.1072994


Unstructured Citation

Holtzman, D.M. (2011). CSF biomarkers for Alzheimer’s disease, current utility and potential future use. Neurobiol Aging, 32 Suppl 1, S4-9.

https://doi.org/10.1016/j.neurobiolaging.2011.09.003


Unstructured Citation

Hoover, B.R., Reed, M.N., Su, J., Penrod, R.D., Kotilinek, L.A., Grant, M.K., Pitstick, R., Carlson, G.A., Lanier, L.M., Yuan, L.L., Ashe, K.H., & Liao, D. (2010). Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron, 68, 6, 1067-1081

https://doi.org/10.1016/j.neuron.2010.11.030


Unstructured Citation

Hyman, B.T., Phelps, C.H., Beach, T.G., Bigio, E.H., Cairns, N.J., Carrillo, M.C., Dickson, D.W., Duyckaerts, C., Frosch, M.P., Masliah, E., Mirra, S.S., Nelson, P.T., Schneider, J.A., Thal, D.R., Thies, B., Trojanowski, J.Q., Vinters, H.V., & Montine, T.J. (2012). National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimers Dement, 8, 1-13.

https://doi.org/10.1016/j.jalz.2011.10.007


Unstructured Citation

Hyman, B.T., & Trojanowski, J.Q. (1997). Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. Journal of Neuropathology & Experimental Neurology, 56, 1095–1097

https://doi.org/10.1097/00005072-199710000-00002


Unstructured Citation

Katzman, R. (1976). Editorial, The prevalence and malignancy of Alzheimer disease. A major killer. Archives of Neurology,33, 217-218


Unstructured Citation

Kessels, H. W., Nguyen, L.N., Nabavi, S., & Malinow, R. (2010). The prion protein as a receptor for amyloid-b. Nature 466, E3-E5.

https://doi.org/10.1038/nature09217


Unstructured Citation

Knopman, D.S., DeKosky, S.T., Cummings, J.L., Chui, H., Corey-Bloom, J., Relkin, N., Small, G.W., Miller, B., & Stevens, J.C. (2001). Practice parameter, diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 56, 1143-1153.

https://doi.org/10.1212/WNL.56.9.1143


Unstructured Citation

Koh, J.Y., Yang, L.L., & Cotman, C.W. (1990). β-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Research, 533, 315-320

https://doi.org/10.1016/0006-8993(90)91355-K


Unstructured Citation

Lee, H.G., Perry, G., Moreira, P.I., Garrett, M.R., Liu, Q., & Zhu, X.W. (2005). Tau phosphorylation in Alzheimer’s disease, pathogen or protector? Trends in Molecular Medicine, 11, 164-169


Unstructured Citation

Mandybur, T.I. (1975). The incidence of cerebral amyloid angiopathy in Alzheimer’s disease. Neurology,25, 120-126

https://doi.org/10.1212/WNL.25.2.120


Unstructured Citation

Marcello, E., Epis R., Saraceno, C., & Di Luca, M. (2012). Synaptic dysfunction in Alzheimer’s disease. Advances in Experimental Medicine and Biology, 970, 573

https://doi.org/10.1007/978-3-7091-0932-8_25


Unstructured Citation

Masters, C.L., Simms, G., Weinman, N.A., Multhaup, G., McDonald, B.L., & Beyreuther, K. (1985). Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proceedings of the National Academy of Sciences of the United States of America, 82, 4245-4249


Unstructured Citation

Meda, L., Cassatella, M.A., Szendrei, G.I., Otvo, L.Jr., Baron, P., Villalba, M., Ferari, D., & Rossi, F. (1995). Activation of microglia cells by beta-amyloid protein and interferon-gamma. Nature, 374, 647-650

https://doi.org/10.1038/374647a0


Unstructured Citation

Mirra, S.S., Heyman, A., McKeel, D., Sumi, S.M., Crain, B.J., Brownlee, L.M., Vogel, F.S., Hughes, J.P., van Belle, G., & Berg, L. (1991). The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology,41, 479-486


Unstructured Citation

Mondragón-Rodríguez, S., Basurto-Islas, G., Lee, H.G., Perry, G., Zhu, X., Castellani, R.J., & Smith, M.A. (2010). Causes versus effects, the increasing complexities of Alzheimer’s disease pathogenesis. Expert Review of Neurotherapeutics, 10, 683-691

https://doi.org/10.1586/ern.10.27


Unstructured Citation

Montine, T.J., & Larson, E.B. (2009). Late-life dementias, does this unyielding global challenge require a broader view? Jama, 302, 2593-2594

https://doi.org/10.1001/jama.2009.1863


Unstructured Citation

Montine, T.J., Phelps, C.H., Beach, T.G., Bigio, E.H., Cairns, N.J., Dickson, D.W., Duyckaerts, C., Frosch, M.P., Masliah, E., Mirra, S.S., Nelson, P.T., Schneider, J.A., Thal, D.R., Trojanowski, J.Q., Vinters, H.V., & Hyman, B.T. (2012). National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease, a practical approach. Acta Neuropathologica, 123, 1-11.

https://doi.org/10.1007/s00401-011-0910-3


Unstructured Citation

Nagy, Z., Yilmazer-Hanke, D.M., Braak, H., Braak, E., Schultz, C., & Hanke, J. (1998). Assessment of the pathological stages of Alzheimer’s disease in thin paraffin sections, a comparative study. Dementia and Geriatric Cognitive Disorders, 9, 140-144

https://doi.org/10.1159/000017038


Unstructured Citation

Nelson, P.T., Schmitt, F.A., Lin, Y., Abner, E.L., Jicha, G.A., Patel, E., Thomason, P.C., Neltner, J.H., Smith, C.D., Santacruz, K.S., Sonnen, J.A., Poon, L.W., Gearing, M., Green, R.C., Woodard, J.L., Van Eldik, L.J., & Kryscio, R.J. (2011). Hippocampal sclerosis in advanced age, clinical and pathological features. Brain, 134, 1506-1518

https://doi.org/10.1093/brain/awr053


Unstructured Citation

Neto, M.R. (2002). Volumetric MRI measurements can differentiate Alzheimer’s disease, mild cognitive impairment, and normal aging. International Psychogeriatrics, 14, 59-72.

https://doi.org/10.1017/S1041610202008281


Unstructured Citation

Puzzo, D., Vitolo, O., Trinchese, F., Jacob, J.P., Palmeri, A., & Arancio, O. (2005). Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity. Journal of Neuroscience, 25, 6887-6897.

https://doi.org/10.1523/JNEUROSCI.5291-04.2005


Unstructured Citation

Querfurth, H.W., & La Ferla, F.M. (2010). Alzheimer’s disease. The New England Journal of Medicine, 36, 329-344.

https://doi.org/10.1056/NEJMra0909142


Unstructured Citation

Ratnavalli, E., Brayne, C., Dawson, K., & Hodges, J. R. (2002). The prevalence of frontotemporal dementia. Neurology, 58, 1615-1621

https://doi.org/10.1212/WNL.58.11.1615


Unstructured Citation

Ravaglia, G., Forti, P., Maioli, F., Sacchetti, L., Mariani, E., Nativio, V., Talerico, T., Vettori, C., & Macini, P.L. (2002). Education, occupation, and prevalence of dementia, findings from the Conselice study. Dementia and Geriatric Cognitive Disorders, 14, 90-100.

https://doi.org/10.1159/000064930


Unstructured Citation

Riedel-Heller, S.G., Busse, A., Aurich, C., Matschinger, H., & Angermeyer, M. C. (2001). Incidence of dementia according to DSM-III-R and ICD-10, results of the Leipzig Longitudinal Study of the Aged (LEILA75+), Part 2. The British Journal of Psychiatry, 179, 255-260

https://doi.org/10.1192/bjp.179.3.255


Unstructured Citation

Roth, M., Tomlinson, B.E., & Blessed, G. (1967). The relationship between quantitative measures of dementia and of degenerative changes in the cerebral grey matter of elderly subjects. Proc R Soc Med., 60, 254-60


Unstructured Citation

Schliebs, R., & Arendt, T. (2011). The cholinergic system in aging and neuronal degeneration. Behavioural Brain Research, 221, 555-563.

https://doi.org/10.1016/j.bbr.2010.11.058


Unstructured Citation

Sherrington, R., Rogaev, E.I., Liang, Y., Rogaeva, E.A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J.F., Bruni, A.C., Montesi, M.P., Sorbi, S., Rainero, I., Pinessi, L., Nee, L., Chumakov, I., Pollen, D., Brookes, A., Sanseau, P., Polinsky, R.J., Wasco, W., Da Silva, H. A., Haines, J.L., Perkicak-Vance, M.A., Tanzi, R.E., Roses, A.D., Fraser, P. E., Rommens, J.M., & St George-Hyslop, P.H. (1995). Cloning of a gene bearing missense mutations in early-onset familial Alzheimer’s disease. Nature, 375, 754-760.

https://doi.org/10.1038/375754a0


Unstructured Citation

Sonnen, J.A., Santa Cruz, K., Hemmy, L.S., Woltjer, R., Leverenz, J.B., Montine, K.S., Jack, C.R., Kaye J., Lim, K., Larson, E.B., White, L., & Montine, T.J. (2011). Ecology of the aging human brain. Archives of Neurology, 68, 1049- 1056

https://doi.org/10.1001/archneurol.2011.157


Unstructured Citation

Summers, W.K., Majovski, L.V., Marsh, G.M., Tachiki, K., & Kling, A. (1986). Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. The New England Journal of Medicine, 315, 1241-1245.

https://doi.org/10.1056/NEJM198611133152001


Unstructured Citation

Tanzi, R.E., Moir, R.D., & Wagner, S.L. (2004). Clearance of Alzheimer’s Abeta peptide, the many roads to perdition. Neuron., 43, 605-608


Unstructured Citation

Terry, R.D., Masliah, E., & Salmon, D.P. (1991). Physical basis of cognitive alterations in Alzheimer’s disease, synapse loss is the major correlate of cognitive impairment. Annals of Neurology, 30, 572-580.

https://doi.org/10.1002/ana.410300410


Unstructured Citation

Vossel, K.A., Zhang, K., Brodbeck, J., Daub, A.C., Sharma, P., Finkbeiner, S., Cui, B., & Mucke, L. (2010). Tau reduction prevents Abeta-induced defects in axonal transport. Science, 330, 198.

https://doi.org/10.1126/science.1194653


Unstructured Citation

Walsh, D.M., Klyubin, I., Fadeeva, J.V., Kulln, W.K., Anwyl, R., Wolfe, M.S, Rowan, M.J., & Selkoe, D.J. (2002). Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature, 416, 535-539.

https://doi.org/10.1038/416535a


Unstructured Citation

Wei, W., Nguyen, L.N., Kessels, H.W., Hagiwara, H., Sisodia, S., & Malinow, R. (2010). Amyloid b from axons and dendrites reduces local spine number and plasticity. Nature Neuroscience, 13, 190-196

https://doi.org/10.1038/nn.2476


Unstructured Citation

Whitehouse, P.J., Price, D.L., Struble, R.G., Clark, A.W., Coyle, J.T., & Delon, M.R. (1982). Alzheimer’s disease and senile dementia, loss of neurons in the basal forebrain. Science, 215, 1237-1239

https://doi.org/10.1126/science.7058341


Unstructured Citation

Wilson, R.S., Leurgans, S.E., Boyle, P.A., Schneider, J.A., & Bennett, D.A. (2010). Neurodegenerative basis of age-related cognitive decline. Neurology, 75, 1070-1078

https://doi.org/10.1212/WNL.0b013e3181f39adc


Unstructured Citation

Yiannopoulou, K.G., & Papageorgiou, S.G. (2013). Current and future treatments for Alzheimer’s disease. Therapeutic Advances in Neurological Disorders, 6, 19-33.

https://doi.org/10.1177/1756285612461679


Unstructured Citation

Zhang, Y., He J.S., Wang, X., Wang, J., Bao, F.X., Pang, S.Y., Yin, F., Hu, H.G., Peng, X.L., Sun, W.M., Zheng, Y.P., Hou, L.L., & Hong, T. (2011). Administration of amyloid-β42 oligomer-specific monoclonal antibody improved memory performance in SAMP8 mice. Journal of Alzheimer's Disease, 23, 551- 561


Unstructured Citation

Zlokovic, B. V. (2004). Clearing amyloid through the blood-brain barrier. Journal of Neurochemistry, 89, 807-811.

https://doi.org/10.1111/j.1471-4159.2004.02385.x


Unstructured Citation

Zlokovic, B.V. (2005). Neurovascular mechanisms of Alzheimer’s neurodegeneration. Trends in Neuroscience, 28, 202-208.

https://doi.org/10.1016/j.tins.2005.02.001